Publication date: Jan 10, 2020
One of the first people in Scotland to take part in a new trial for Huntington’s disease (HD) says the programme has taken him from a -real place of darkness”.
The research, led by Zosia Miedzybrodzka at the University of Aberdeen, aims to find out if a new gene blocking compound can slow progression of the disease.
The 57-year-old said: -Huntington’s disease has had a massive effect on all my family.
Mr Patience travels every two months from his home in Inverness to Aberdeen Royal Infirmary where a sample of his brain fluid is taken for analysis, after which a trial drug or a placebo is administered.
He added: -I’m hoping against hope that I am on the trial drug but even if I’m on the placebo the trial has had a very positive effect on my life.
- Huntington’s clinical trial opens a door to hope – but only if patients get in
- New therapies for Huntington’s disease: is the endgame in sight?